Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest

Ian S. Fraser, Susanne Parke, Uwe Mellinger, A. Machlitt, Andrea Machlitt, Marco Serrani, Jeffrey T. Jensen, Jeffrey Jensen
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2011 · vol. 16(4) , pp. 258–269 · doi:10.3109/13625187.2011.591456 · PMID:21774563 · PMC3154543 · W2055120676
article OA: gold CC0 ⤵ 23 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

OBJECTIVES: To evaluate the efficacy of oestradiol valerate/dienogest (E2V/DNG) for the treatment of heavy and/or prolonged menstrual bleeding without organic pathology based on the analysis of data from two identically designed double-blind, randomised studies. METHODS: Women aged ≥ 18 years with heavy and/or prolonged menstrual bleeding were randomised to E2V/DNG (n = 269) or placebo (n = 152) for 196 days. Objective changes in menstrual blood loss (MBL) volume were assessed using the alkaline haematin method. RESULTS: After six months of treatment, median MBL decreased by 88% with E2V/DNG compared with 24% with placebo. The greatest reduction was achieved at the first withdrawal bleed after treatment initiation and it was sustained with no loss of effect throughout treatment. CONCLUSION: E2V/DNG was more effective than placebo in reducing MBL in women with heavy and/or prolonged menstrual bleeding without organic pathology. The reduction was largely achieved as early as the first withdrawal bleed, with further gradual improvement throughout treatment.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Cited by (23)

Source provenance

crossref
last seen: 2026-05-16T01:00:26.756795+00:00
europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-05-14T06:05:00.350814+00:00
License: CC0 · commercial use OK